Maze Therapeutics (MAZE) Accumulated Depreciation & Amortization (2024 - 2025)

Maze Therapeutics has disclosed Accumulated Depreciation & Amortization across 2 years of filings, most recently posting $19.2 million for Q4 2025.

• Accumulated Depreciation & Amortization for Q4 2025 came in at $19.2 million, up 13.9% year-over-year; the trailing twelve-month figure through Dec 2025 was $19.2 million (up 13.9% YoY), and the FY2025 annual result was $19.2 million, up 13.9% from the prior year.
• Accumulated Depreciation & Amortization came in at $19.2 million for Q4 2025 at Maze Therapeutics, up from $16.9 million in the prior quarter.
• In the past five years, Accumulated Depreciation & Amortization ranged from a high of $19.2 million in Q4 2025 to a low of $16.9 million in Q4 2024.